Literature DB >> 15228723

The in-vitro antimalarial activity of ferrochloroquine, measured against Cambodian isolates of Plasmodium falciparum.

P Chim1, P Lim, R Sem, S Nhem, L Maciejewski, T Fandeur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15228723     DOI： 10.1179/000349804225003361

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  9 in total

1.  Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.

Authors:  Jutta Marfurt; Ferryanto Chalfein; Pak Prayoga; Frans Wabiser; Enny Kenangalem; Kim A Piera; Barbara Machunter; Emiliana Tjitra; Nicholas M Anstey; Ric N Price
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

2.  In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.

Authors:  Maud Henry; Sébastien Briolant; Albin Fontaine; Joel Mosnier; Eric Baret; Rémy Amalvict; Thierry Fusaï; Laurent Fraisse; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

Review 3.  The antimalarial ferroquine: from bench to clinic.

Authors:  C Biot; F Nosten; L Fraisse; D Ter-Minassian; J Khalife; D Dive
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

Review 4.  Ferroquine and its derivatives: new generation of antimalarial agents.

Authors:  Waseem A Wani; Ehtesham Jameel; Umair Baig; Syed Mumtazuddin; Lee Ting Hun
Journal:  Eur J Med Chem       Date:  2015-07-08       Impact factor: 6.514

5.  Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.

Authors:  Wassim Daher; Christophe Biot; Thierry Fandeur; Helene Jouin; Lydie Pelinski; Eric Viscogliosi; Laurent Fraisse; Bruno Pradines; Jacques Brocard; Jamal Khalife; Daniel Dive
Journal:  Malar J       Date:  2006-02-07       Impact factor: 2.979

6.  In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border.

Authors:  Marion Barends; Anchalee Jaidee; Nopparat Khaohirun; Pratap Singhasivanon; François Nosten
Journal:  Malar J       Date:  2007-06-27       Impact factor: 2.979

7.  A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.

Authors:  James S McCarthy; Thomas Rückle; Elhadj Djeriou; Cathy Cantalloube; Daniel Ter-Minassian; Mark Baker; Peter O'Rourke; Paul Griffin; Louise Marquart; Rob Hooft van Huijsduijnen; Jörg J Möhrle
Journal:  Malar J       Date:  2016-09-13       Impact factor: 2.979

8.  Ferroquine, an ingenious antimalarial drug: thoughts on the mechanism of action.

Authors:  Faustine Dubar; Jamal Khalife; Jacques Brocard; Daniel Dive; Christophe Biot
Journal:  Molecules       Date:  2008-11-20       Impact factor: 4.411

Review 9.  Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial.

Authors:  Daniel Dive; Christophe Biot
Journal:  ChemMedChem       Date:  2008-03       Impact factor: 3.466
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.